Browse > Article
http://dx.doi.org/10.5762/KAIS.2011.12.10.4411

A Study on the R&D Trend and Patent Analysis of Treatments for Degenerative Brain Diseases  

Sohn, Eun-Soo (Korea Institute of Science and Technology Information)
Sohn, Eun-Hwa (Department of Herbal Medicine Resource, Kangwon National University)
Publication Information
Journal of the Korea Academia-Industrial cooperation Society / v.12, no.10, 2011 , pp. 4411-4417 More about this Journal
Abstract
Degenerative brain diseases including Alzheimer's diseases, Parkinson's diseases increase in frequency with age. They are amongst the most costly and devastating diseases to patients and their families. Therefore developing therapies for degenerative brain diseases is of the highest priority. Recently therapeutics for these diseases have undergone scrutiny by many clinical trials according to the advances of cellular and molecular neurobiology. This review is focused on studies investigating the current therapeutic strategies already undergone different stage of clinical trials and recent R&D trend by nations through patent analysis on treatments for degegerative brain diseases.
Keywords
Alzheimer's Disease; Degenerative Brain Disease; Parkinson's diseases; Technology Trend; Patent Analysis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Carreiras MC, Marco JL, "Recent approaches to novel anti-Alzheimer therapy", Curr Pharm Des., 10(25), pp.3167-3175, 2004.   DOI
2 Collins S, Sigtermans MJ, Dahan A, Zuurmond WW, Perez RS., "NMDA receptor antagonists for the treatment of neuropathic pain", Pain Med. 11(11), pp.1726-1742, 2010.   DOI
3 Alan H Nagahara1, David A Merrill1 et al., "Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease" Nature Medicine 15, pp.331-337, 2009.   DOI
4 A. Rocchi, S. Pellegrini, G. Siciliano and L. Murri, "Causative and susceptibility genes for Alzheimer's disease: a review", Brain Res. Bull., 61(1), pp.1-24, 2003.   DOI
5 Kerchner GA, Boxer AL., "Bapineuzumab", Expert Opin Biol Ther. 10(7), pp.1121-1130, 2010.   DOI
6 L. Aron and R. Klein, "Repairing the parkinsonian brain with neurotrophic factors", Trends Neurosci. 34(2), pp.88-100, 2011.   DOI
7 L. Y. Fan and M. J. Chiu, "Pharmacological treatment for Alzheimer's disease: current approaches and future strategies", Acta Neurol Taiwan. 19(4), pp.228-245, 2010.
8 Simmons DA, Rex CS, Palmer L, Pandyarajan V, Fedulov V, Gall CM, Lynch G., "Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice", Proc Natl Acad Sci USA. 24;106(12), pp.4906-4911, 2009.   DOI
9 Lim ST, Airavaara M, Harvey BK., "Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNS", Pharmacol Res. 61(1), pp.14-26, 2010.   DOI
10 Wu YP, Chen WS, Teng C, Zhang N., "Stem cells for the treatment of neurodegenerative diseases", Molecules 15; pp.6743-6758, 2010.   DOI
11 Z. Griliches, Patent statistics as economic indicators: A survey, Journal of economic literature, 18, pp.1661-1707, 1990.
12 S. K. Sonkusare et al., "Dementia of Alzheimer's disease and other neurodegenerative disorders-memantine, a new hope", Pharmacological Research, 51(1), pp.1-17, 2005.   DOI
13 P. Stanzione and D. Tropepi. "Drugs and clinical trials in neurodegenerative diseases", Ann Ist Super Sanita, 47(1), pp.49-54, 2011.
14 Alan L. Porter and Scott W. Tech Mining: Exploiting New Technologies for Competitive Advantage, Cunningham, Hoboken, NJ, John Wiley & Sons, 33-40. 2005.
15 Halperin I, Morelli M, Korczyn AD, Youdim MB, Mandel SA., "Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer's and Parkinson's diseases", Neurotherapeutics. 6(1), pp.128-140, 2009.   DOI
16 J.B. Standridge, "Pharmacotherapeutic approaches to the treatment of Alzheimer's disease", Clin. Ther., 26(5), pp.615-630, 2004.   DOI